Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.30%)
As of: Sep 3, 2026 · 2:44 PM EDT

Starling Oncology (STLN) Non Operating Income (2021 - 2026)

Analysis

Starling Oncology (STLN) Non Operating Income (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 HCA Healthcare 90.68 Bn 89.67 Bn 15.19 Bn -
2 Tenet Healthcare 22.03 Bn 19.86 Bn 4.45 Bn -
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn -
4 Davita 11.73 Bn 11.05 Bn 1.16 Bn -
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn -
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn 11.17 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 3.91 Mn
8 Pacs 6.68 Bn 6.51 Bn 338.46 Mn -3.49 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn -
10 Starling Oncology 613.04 Mn 571.94 Mn 27.17 Mn -5.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.17 Mn
Mar 31, 2026 4.02 Mn
Dec 31, 2025 -601,000.00
Sep 30, 2025 -8.45 Mn
Jun 30, 2025 -5.93 Mn
Mar 31, 2025 -9.67 Mn
Dec 31, 2024 -1.25 Mn
Sep 30, 2024 -2.26 Mn
Jun 30, 2024 885,000.00
Mar 31, 2024 -1.92 Mn
Dec 31, 2023 -3.78 Mn
Sep 30, 2023 -3.36 Mn
Jun 30, 2023 -1.86 Mn
Mar 31, 2023 2.91 Mn
Dec 31, 2022 13.71 Mn
Sep 30, 2022 17.40 Mn
Jun 30, 2022 12.82 Mn
Mar 31, 2022 37.94 Mn
Dec 31, 2021 28.21 Mn
Sep 30, 2021 -24,000.00